Associação da obesidade com mortes por COVID-19: uma revisão narrativa
DOI:
https://doi.org/10.34024/rnc.2022.v30.12998Palavras-chave:
Obesidade, Pandemias, Infecções por Coronavírus, Síndrome Respiratória Aguda GraveResumo
Introdução. A obesidade mostrou aumentar a vulnerabilidade a infecções, servindo como um fator de risco entre a taxa de mortalidade de pacientes com COVID-19. Objetivo. Apresenta como objetivo verificar a associação da obesidade com mortes por COVID-19. Método. A busca por artigos científicos foi conduzida por dois pesquisadores independentes nas bases de dados Medline (Pubmed), LILACS, SciELO, Web Of Science, Bireme e Scopus, sem restrição de idioma, período e localização. Para complementar e evitar viés de risco foi realizada uma busca por literatura cinza no Google Scholar. Foram inclusos na pesquisa estudos que obtiveram pontuação ≥ a 6 pontos segundo o protocolo para pontuação qualitativa proposto por Pithon et al. Resultados: Os estudos mostram que a obesidade desempenha um papel significativo no risco de morte por COVID-19. Em pacientes que morreram devido à COVID-19, a obesidade está associada a um aumento da probabilidade de complicações não respiratórias. Além disso, a COVID-19 aumentou o risco de mortalidade em pacientes que apresentam obesidade quase cinco vezes mais. Conclusão. Os efeitos do Índice de Massa Corporal em pacientes que apresentam obesidade foram associados à maior letalidade quando diagnosticados com a COVID-19. Pacientes com obesidade, especialmente aqueles com obesidade grave, devem tomar precauções extras para evitar a contaminação por COVID-19 durante a pandemia.
Downloads
Métricas
Referências
de Souza TA, Siqueira BS, Grassiolli S. Obesidade, comorbidades e covid19: Uma breve revisão de literatura. Varia Sci Agrár 2020;6:72-82. https://doi.org/10.48075/vscs.v6i1.25403
de Siqueira JVV, Almeida LG, Zica BO, Brum IB, Barceló A, de Siqueira Galil AG. Impact of obesity on hospitalizations and mortality, due to COVID-19: a systematic review. Obes Res Clin Pract 2020;14:398-403. https://doi.org/10.1016/j.orcp.2020.07.005
Tartof SY, Qian L, Hong VWR, Nadjafi RF, Fischer H, Li Z, et al. Obesity and Mortality Among Patients Diagnosed With COVID-19: results from an integrated health care organization. Ann Intern Med 2020;173:773-81. https://doi.org/10.7326/M20-3742
Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: a systematic review. Diabetes Metab Syndr 2020;14:655-9. https://doi.org/10.1016/j.dsx.2020.05.020
Aghili SMM, Ebrahimpur M, Arjmand B, Shadman Z, Sani NP, Qorbani M, et al. Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis. Int J Obes 2021;45:998-1016. https://doi.org/10.1038/s41366-021-00776-8
Zhang X, Lewis AM, Moley JR, Brestoff JR. A systematic review and meta-analysis of obesity and COVID-19 outcomes. Sci Rep 2021;11:1-11. https://doi.org/10.1038/s41598-021-86694-1
Malik P, Patel U, Patel K, Martin M, Shah G, Mahta D, et al. Obesity a predictor of outcomes of COVID‐19 hospitalized patients—A systematic review and meta‐analysis. J Med Virol 2020;93:1188-93. https://doi.org/10.1002/jmv.26555
Malik VS, Ravindra K, Attri SA, Bhadada SK, Singh M. Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis. Environ Sci Pollut Res 2020;27:42115-23. https://doi.org/10.1007/s11356-020-10132-4
Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, et al. Obesity is Associated with Worse Outcomes in COVID‐19: analysis of early data from new york city. Obesity 2020;28:1606-12. https://doi.org/10.1002/oby.22923
Pettit NN, Mackenzie EL, Ridgway JP, Pursell K, ASH D, Patel B, et al. Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID‐19. Obesity 2020;28:1806-10. https://doi.org/10.1002/oby.22941
Busetto L, Bettini S, Fabris R, Serra R, PRA CD, Mafffei P, et al. Obesity and COVID‐19: an italian snapshot. Obesity 2020;28:1600-5. https://doi.org/10.1002/oby.22918
Lockhart SM, O’rahilly S. When Two Pandemics Meet: why is obesity associated with increased covid-19 mortality? Med 2020;1:33-42. https://doi.org/10.1016/j.medj.2020.06.005
Moher D, Shamseer L, Clarke M. Preferred reporting items for systematic review and meta analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1. https://doi.org/10.1136/bmj.m2632
Pithon MM, Sant'anna LIDA, Baião FCS, Santos RL, Coqueiro RS, Maia LC. Assessment of the effectiveness of mouthwashes in reducing cariogenic biofilm in orthodontic patients: a systematic review. J Dent 2015;43:297-308. https://doi.org/10.1016/j.jdent.2014.12.010
Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas À, et al. Predicting Mortality Due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to covid-19 outcomes in mexico. J Clin Endocrinol Metab 2020;105:2752-61. https://doi.org/10.1210/clinem/dgaa346
Onder G, Palmieri L, Vanacore N, Giuliano M, Brusaferro S, Palmeri L, et al. Nonrespiratory Complications and Obesity in Patients Dying with COVID‐19 in Italy. Obesity 2020;29:20-3. https://doi.org/10.1002/oby.23007
Huh K, Lee R, Ji W, Kang M, Hwang IC, Lee DH, et al. Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: a matter of sexual dimorphism? Diabetes Res Clin Pract 2020;170:108515. https://doi.org/10.1016/j.diabres.2020.108515
Engin AB, Engin ED, Engin A. Two important controversial risk factors in SARS-CoV-2 infection: obesity and smoking. Environ Toxicol Pharmacol 2002;78:103411. https://doi.org/10.1016/j.etap.2020.103411
Rebello CJ, Kirwan JP, Greenway FL. Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link? Int J Obes 2020;44:1810-7. https://doi.org/10.1038/s41366-020-0640-5
Brahe LK, Astrup A, Larsen LH. Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota? Adv Nutr 2016;7:90-101. https://doi.org/10.3945/an.115.010587
Enes CC, Slater B. Obesidade na adolescência e seus principais fatores determinantes. Rev Bras Epidemiol 2010;13:163-71. https://doi.org/10.1590/S1415-790X2010000100015
Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID‐19: a global perspective on the epidemiology and biological relationships. Obes Rev 2020;21:1-9. https://doi.org/10.1111/obr.13305
Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the united states. Mol Psychiatry 2020;26:30-9. https://doi.org/10.1038/s41380-020-00880-7
Siqueira LD, Muchon JD, Arruda JT, dos Reis Paludo RL. Análise da mortalidade por COVID-19 e obesidade como fator de risco. Pesq Soc Desenvolv 2022;11:e10911123432. https://doi.org/10.33448/rsd-v11i1.23432
Silva Neto JG, Braga FA, Moura GV, Cavalcante SKCC, Oliveira LEA, Sousa EFG, et al. Relação da obesidade com o agravamento da COVID-19. Pesq Soc Desenvolv 2022;1:e25711326617. https://doi.org/10.33448/rsd-v11i3.26617
Carneiro RAVD, Hillesheim D, Hallal ALC. Correlation of overweight condition and obesity with mortality by COVID-19 in Brazil’s state capitals. Arch Endocrinol Metab 2021;65:386-91. https://doi.org/10.20945/2359-3997000000351
Souza FSH, Hojo-Souza NS, Batista BDO, Silva CM, Guidoni DL. On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database. PLOS
ONE 2021;16:e0248580. https://doi.org/10.1371/journal.pone.0248580
Palaiodimos L, Ali R, Teo HO, Parthasarathy S, Karamanis D, Chamorro-Pareja N, et al. Obesity, Inflammation, and Mortality in COVID-19: An Observational Study from the Public Health Care System of New York City. J Clin Med 2022;11:622. https://doi.org/10.3390/jcm11030622
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2022 Laura Faustino Gonçalves, Rodrigo Sudatti Delevatti, Patricia Haas

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Aceito: 2022-07-20
Publicado: 2022-08-31